Massive Bio has made its inaugural strategic investment in Rivvi. Read the announcement

2027 Star Ratings

H2425

Blue Plus

15,072 members

3.5

-0.5 vs 2026Below the 4 star line

Ask about H2425

3 free questions today

Medication adherence

Medication Adherence for Diabetes Medications

3 · 1.0 pt to 4★

Medication Adherence for Hypertension (RAS antagonists)

4 · 3.0 pt to 5★

Medication Adherence for Cholesterol (Statins)

4 · 2.0 pt to 5★

All measures

MeasureStarsScore
C27 Complaints about the Health Plan50.09
C28 Members Choosing to Leave the Plan54%
C17 Plan All-Cause Readmissions3x212%
C10 Osteoporosis Management in Women who had a Fracture119%
C16 Improving Bladder Control345%
C06 Monitoring Physical Activity246%
C20 Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions154%
C13 Kidney Health Evaluation for Patients with Diabetes256%
C03 Annual Flu Vaccine364%
C01 Breast Cancer Screening267%

Other plans from this organization

Source: CMS 2027 Part C and D Star Ratings data, released October 8, 2026. Data loaded October 9, 2026.

Try it on your own data today.

Free to start. Most teams are using it the same day.